Jacob Gary S insider trades
Jacob Gary S has filed 5 Form 4s with the SEC that we hold, for OKYO Pharma Ltd (OKYO) (CHIEF DEVELOPMENT OFFICER, Director), Hepion Pharmaceuticals, Inc. (HEPA) (Director) and VRPX (Director). Across all of them we count 2 purchases worth $54.9K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($4.9K) and 0 sales ($0). The largest single trade was a purchase of 12,500 shares of OKYO Pharma Ltd worth $50.0K, dated 2022-05-19. The first filing on our record is dated 2022-01-05 and the latest 2026-08-07.
OKYO Pharma Ltd (OKYO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-19 | P, purchase reported on Form 4 | 12,500 | $50.0K | 2022-05-19 |
| 2026-07-21 | P, purchase reported on Form 4 | 3,500 | $4.9K | 2026-08-07 |
Hepion Pharmaceuticals, Inc. (HEPA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
VRPX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1266802) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms